Independent component analysis for assessing therapeutic response in vitiligo skin disorder
- PMID: 19205989
- DOI: 10.1080/03091900802454459
Independent component analysis for assessing therapeutic response in vitiligo skin disorder
Abstract
This paper describes an image analysis technique that objectively measures skin repigmentation for the assessment of therapeutic response in vitiligo treatments. Skin pigment disorders due to the abnormality of melanin production, such as vitiligo, cause irregular pale patches of skin. The therapeutic response to treatment is repigmentation of the skin. However the repigmentation process is very slow and is only observable after a few months of treatment. Currently, there is no objective method to assess the therapeutic response of skin pigment disorder treatment, particularly for vitiligo treatment. In this work, we apply principal component analysis followed by independent component analysis to represent digital skin images in terms of melanin and haemoglobin composition respectively. Vitiligo skin areas are identified as skin areas that lack melanin (non-melanin areas). Results obtained using the technique have been verified by dermatologists. Based on 20 patients, the proposed technique effectively monitored the progression of repigmentation over a shorter time period of six weeks and can thus be used to evaluate treatment efficacy objectively and more effectively.
Similar articles
-
Computerised image analysis of vitiligo lesion: evaluation using manually defined lesion areas.Skin Res Technol. 2013 Feb;19(1):e72-7. doi: 10.1111/j.1600-0846.2011.00610.x. Epub 2012 Jan 11. Skin Res Technol. 2013. PMID: 22233154
-
Determination of skin repigmentation progression.Annu Int Conf IEEE Eng Med Biol Soc. 2007;2007:3442-5. doi: 10.1109/IEMBS.2007.4353071. Annu Int Conf IEEE Eng Med Biol Soc. 2007. PMID: 18002737
-
Optimal weekly frequency of 308-nm excimer laser treatment in vitiligo patients.Br J Dermatol. 2005 May;152(5):981-5. doi: 10.1111/j.1365-2133.2004.06321.x. Br J Dermatol. 2005. PMID: 15888156 Clinical Trial.
-
Update on skin repigmentation therapies in vitiligo.Pigment Cell Melanoma Res. 2009 Feb;22(1):42-65. doi: 10.1111/j.1755-148X.2008.00528.x. Epub 2008 Nov 27. Pigment Cell Melanoma Res. 2009. PMID: 19040503 Review.
-
New insights on therapy with vitamin D analogs targeting the intracellular pathways that control repigmentation in human vitiligo.Med Res Rev. 2009 May;29(3):514-46. doi: 10.1002/med.20146. Med Res Rev. 2009. PMID: 19241402 Review.
Cited by
-
Quantitative principal component model for skin chromophore mapping using multi-spectral images and spatial priors.Biomed Opt Express. 2011 Apr 1;2(5):1040-58. doi: 10.1364/BOE.2.001040. Biomed Opt Express. 2011. PMID: 21559118 Free PMC article.
-
Principal component model of multispectral data for near real-time skin chromophore mapping.J Biomed Opt. 2010 Jul-Aug;15(4):046007. doi: 10.1117/1.3463010. J Biomed Opt. 2010. PMID: 20799809 Free PMC article.
-
Evaluation of non-invasive multispectral imaging as a tool for measuring the effect of systemic therapy in Kaposi sarcoma.PLoS One. 2013 Dec 27;8(12):e83887. doi: 10.1371/journal.pone.0083887. eCollection 2013. PLoS One. 2013. PMID: 24386302 Free PMC article.
-
Objective Assessment of Skin Repigmentation Using a Multilayer Perceptron.J Med Signals Sens. 2019 Apr-Jun;9(2):88-99. doi: 10.4103/jmss.JMSS_52_18. J Med Signals Sens. 2019. PMID: 31316902 Free PMC article.
-
Non-invasive skin measurement methods and diagnostics for vitiligo: a systematic review.Front Med (Lausanne). 2023 Jul 27;10:1200963. doi: 10.3389/fmed.2023.1200963. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37575985 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical